At Houston Methodist, we have made great discoveries in the areas of transplantation research by aligning our laboratories and scientists with our state-of-the-art patient care activities. Our ￼research team focuses on improving successful transplant outcomes by exploring innovative ways to improve transplant health, reduce transplant rejection while concurrently discovering methods to help avoid life-long dependency on rejection-halting immunosuppressive drugs. We are also investigating new technologies for synthetic transplants in an effort to increase the number of organs available for transplantation. Our researchers are addressing transplant-related issues including graft injury and repair, stem cells and tissue regeneration, transplant rejection, tolerance-compatible immunosuppression and identification of biomarkers for rejection or tolerance. Our researchers are also actively involved in clinical trials to find new forms of immunosuppression, strategies for reducing complications and new ways to fight post-operative infection.
Civacir Trial for Hepatitis C
David Victor, MD is investigating the efficacy of Civacir polyclonal IgG to prevent Hepatitis C recurrence in liver transplant patients. Learn more.
A. Osama Gaber, MD
Osama Gaber, MD is the J.C. Walter Jr. Transplant Center Distinguished Endowed Chair and Professor of Surgery. Learn More.
$6.5 Million Gift Expands Liver Center
Sherrie and Alan Conover donated a $6.5 million gift to the Houston Methodist Liver Center to support research, education, after hours resources for caregivers and family members. Learn More.
Memory B Cells in Transplant Rejection
Roger Sciammas, PhD received $1.6M from the NIH to track the life cycle of all-specific memory B cells to help control transplant rejection. Learn More.